30 Participants Needed

Portable Driving Simulator for Neurological Conditions

AE
Overseen ByAbiodun E Akinwuntan, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Kansas Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new portable driving simulator designed to help individuals with neurological conditions such as stroke, Parkinson's disease, or multiple sclerosis improve their driving skills. The researchers aim to determine if this simpler, low-cost simulator can match the effectiveness of a more complex one in helping users maintain lane position, follow speed limits, and react to traffic signals, all without causing simulator sickness. Participants will use either the new portable simulator or the traditional high-tech one for a total of five hours and undergo assessments before and after the training. This trial suits those who have experienced a stroke, Parkinson's, or MS; hold a valid driver's license with at least three years of driving experience; and meet basic vision and cognitive criteria. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance driving safety for individuals with neurological conditions.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the study team or your doctor.

What prior data suggests that this portable driving simulator is safe for patients with neurological conditions?

Research shows that the Portable Driving Simulator (PDS) under testing is designed for ease of use and affordability. It aims to help individuals with conditions like stroke, Parkinson's disease (PD), or multiple sclerosis (MS) enhance their driving skills. The PDS offers a simpler and cheaper alternative to more advanced simulators.

Studies have found that advanced simulators can sometimes cause simulator sickness, similar to motion sickness, resulting in dizziness or nausea. The new PDS aims to reduce these issues. Early results suggest that the PDS might be easier to use and could cause less simulator sickness than advanced options.

The simple setup of the PDS might lead to fewer side effects for users. However, as this study is still in its early stages, more data is needed to confirm its safety. Participants in the trial might find the PDS a safer option with fewer chances of causing simulator sickness.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores the use of a Portable Driving Simulator (PDS) as a novel approach for individuals with neurological conditions like stroke, Parkinson's disease, or multiple sclerosis. Unlike traditional rehabilitation methods, which often emphasize physical therapy and medication, this trial investigates how immersive simulation can enhance cognitive and motor skills crucial for driving. The High Fidelity Fixed-Base Simulator Training offers a more realistic driving experience, potentially leading to better real-world driving skills, while the Low-Fidelity PDS Training provides a more accessible and flexible option. This innovative approach could redefine rehabilitation by offering personalized and scalable solutions to improve the quality of life for those affected by these conditions.

What evidence suggests that the Portable Driving Simulator is effective for retraining driving skills in neurological conditions?

Research has shown that driving simulators can enhance driving skills and brain functions in individuals with neurological conditions such as stroke, Parkinson's disease (PD), and multiple sclerosis (MS). In this trial, participants will train with either the Low-Fidelity Portable Driving Simulator (PDS) or the High Fidelity Fixed-Base Simulator. Studies suggest that the PDS may be as effective as more advanced simulators in helping patients regain skills like lane-keeping and speed control. The PDS is also designed for ease of use and may cause less simulator sickness, which often disrupts training. This makes it a more comfortable option for patients, offering a promising tool for relearning driving skills.12346

Who Is on the Research Team?

AA

Abiodun Akinwuntan, PhD, MPH MBA

Principal Investigator

University of Kansas School of Health Professions

Are You a Good Fit for This Trial?

This trial is for individuals with a first-ever stroke, Parkinson's disease (PD), or multiple sclerosis (MS) who have valid driver's licenses and at least 3 years of driving experience. They must score ≥24 on the Mini-mental State Examination and have binocular acuity meeting Kansas driving laws.

Inclusion Criteria

Mini-mental State Examination score ≥24, and
I have been diagnosed with stroke, Parkinson's disease, or multiple sclerosis for the first time.
I have a valid driver's license and over 3 years of driving experience.
See 1 more

Exclusion Criteria

I have a brain injury or another neurological condition, but not stroke, Parkinson's, or MS.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Pre-training Evaluation

Participants undergo driving-related physical, visual, and cognitive tests

1 week
1 visit (in-person)

Training

Participants receive five hours of simulator training to improve driving skills

2 weeks
5 visits (in-person)

Post-training Evaluation

Participants undergo a post-training evaluation similar to the pre-training evaluation

1 week
1 visit (in-person)

Follow-up

Participants are monitored for any long-term effects or improvements in driving skills

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Portable Driving Simulator
Trial Overview The study compares a low-cost portable driving simulator (PDS) to a high-fidelity fixed-base simulator in retraining driving skills. Participants will be randomly assigned to one of these tools for training and evaluated before and after the sessions.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Low-Fidelity PDS TrainingExperimental Treatment1 Intervention
Group II: High Fidelity Fixed-Base Simulator TrainingActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Kansas Medical Center

Lead Sponsor

Trials
527
Recruited
181,000+

Published Research Related to This Trial

In a study involving 30 healthy subjects, the driving simulator (CRCDS Mini-Sim) effectively detected impairment in driving ability caused by 7.5 mg of zopiclone, a hypnotic medication.
The administration of zopiclone resulted in a significant increase in the standard deviation of lateral lane position (SDLP) by 2.62 cm, indicating impaired driving, which aligns closely with results from traditional on-the-road driving assessments.
A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone.Simen, AA., Gargano, C., Cha, JH., et al.[2020]
A study involving 56 neurological patients showed that the newly installed driving simulator at the Neurological Rehabilitation Centre was positively received, indicating good patient acceptance of this rehabilitation method.
Patients found the driving simulator to be motivating, effective, and informative, which is crucial for its successful implementation in assessing and rehabilitating driving ability.
[Interactive driving simulation--a new approach to diagnosis and rehabilitation of driving skills].Wolbers, T., Küst, J., Karbe, H., et al.[2006]
A pilot study involving four drivers with Parkinson's disease showed that a rehabilitation program using a driving simulator led to a reduction in crashes and improved decision-making skills during simulated driving scenarios.
Three out of four participants demonstrated significant improvements in their driving performance on a standard road test after the training sessions, indicating that simulator training may be a beneficial intervention for drivers with Parkinson's disease.
DRIVER REHABILITATION IN PARKINSON'S DISEASE USING A DRIVING SIMULATOR: A PILOT STUDY.Uc, E., Rizzo, M., Anderson, S., et al.[2021]

Citations

User-friendliness of a Portable Driving Simulator | ...The use of simulators to retrain driving skills of patients with stroke, Parkinson's disease (PD), or multiple sclerosis (MS) is very limited because of ...
User-friendliness of a Portable Driving Simulator to Retrain ...To compare the benefits of retraining impaired driving skills of persons with MS and PD using the PDS and a high-fidelity simulator (HFS).
User-friendliness of a Portable Driving SimulatorStudy Design. The study involves 30 participants with stroke, Parkinson's disease, or multiple sclerosis, randomly assigned to either the PDS ...
Portable Driving Simulator for Neurological ConditionsResearch shows that driving simulators can be effective in improving driving skills and cognitive functions in people with neurological conditions like ...
User-friendliness of a Portable Driving Simulator - Clini...... driving-related skills after stroke and with promise in individuals with Parkinson's disease (PD) or multiple sclerosis (MS). Driving ...
User-friendliness of a Portable Driving SimulatorThe use of simulators to retrain driving skills of patients with stroke, Parkinson's disease (PD), or multiple sclerosis (MS) is very limited because of cost, ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security